NCT03366766 2026-02-20Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung CancerThomas Jefferson UniversityPhase 2 Terminated14 enrolled 16 charts
NCT04458909 2025-10-03Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal CancerNational Cancer Institute (NCI)Phase 3 Terminated15 enrolled 17 charts